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Introduction
Esophageal cancer is the 6th most common cancer in
the world1 with worldwide incidence of 20/100,000
individuals. It is more prevalent in some parts of world
like South Africa and China with incidence reaching up
to 160/100,000 individuals. Either squamous or
adenocarcinoma, its typical presentation is progressive
dysphagia which is initially for solids and later on for
liquids. Endoscopy is used for diagnosis and biopsy of
the lesion. Staging of disease can be done by CT scan,
PET-CT, Endoluminal Ultrasound, bronchoscopy and
diagnostic laparoscopy with different diagnostic
accuracies for Tumour site, nodal status and distant
metastasis were used for each of these. For Cervical
esophageal tumours, chemo radiation is the definitive
treatment.2 For mid and lower esophageal cancers,
whether it is squamous or Adenocarcinoma, treatment is
stage dependent. For early tumours upfront resection is
advised as per NCCN guidelines.2 For resectable tumours
with nodal spread and involving Muscularis Propria,
there is enough evidence3 to support Neoadjuvant
chemo radiation either with or without adjuvant
treatment. Hence it is very important to determine the
exact stage of disease to properly plan most effective
treatment strategy. EUS which is most sensitive for
tumour size and nodal evaluation needs expensive
instruments, expertise and is not readily available at
every center. CT scan which has low sensitivity for
tumour size and nodal status is widely available, easy to
report and high sensitivity for distant metastasis. This
Study was conducted to find out the sensitivity and
specificity of respectable mid and lower Esophageal
cancers.
Material and Methods
It was a retrospective Audit conducted at Aga Khan
University Hospital Karachi . Exemption from an ethical
review committee of the institute was obtained. All
patients who underwent upfront surgery (Iwor Lewis' two
stage esophagectomy with reconstruction with gastric
tube) for resectable mid and lower esophageal cancers
and CT scan done from Aga Khan University Hospital
Karachi from January 2008 to July 2014 were included in
the study. CT scans were done at 64 slice spiral CT scanner
with IV contrast and slice thickness of 3mm. The patients
with neoadjuvant treatment or Preoperative CT scan from
outside Aga Khan University Hospital Karachi were
excluded.
ICD coding 142.41 was used to obtain medical record
numbers of patients who underwent two stage
esophagectomy during the above mentioned time
period. Files were reviewed by the Primary investigator for
age, gender, days between preoperative CT scan and
surgery, histopathology and histopathological TN stage of
tumour. CT scans of patients were separately reviewed by
a Consultant Radiologist to record radiological T&N stage
of tumour who was blinded for histopathological stage of
disease. Data was entered on SPSS19. Continuous
variables were expressed in Means ± SD and categorical
variables were expressed in proportions. Accuracy,
specificity and sensitivity of tumour and nodal status were
measured by comparing a radiological TN stage with
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Introduction: CT scan is an important tool in staging of esophageal cancer. Survival can be improved by providing
neoadjuvant treatment which depends on stage of esophageal cancer. So it is very important to stage the disease
accurately.
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stage of tumour. Diagnostic accuracy measured by comparing with histopathological staging.
Results: Accuracy, sensitivity and specificity of CT for T2 and T3 are 66%, 61%, 68% and 63%, 67%, 56% respectively.
Accuracy, sensitivity and specificity of CT for presence of nodal disease are 65%, 59% and 75%.
Conclusion: Ct scan alone has low diagnostic accuracy for staging Esophageal Cancer.
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histopathological TN stage using 2X2 tables.
Results
Total number of files obtained were 155, 93 patients were
excluded on the basis of exclusion criteria. 62 patients
were included in the study. Mean age of patients was
52.6±11.8 years and 39 (62.9%) patients were males. Time
lag between Preoperative CT scan and surgery was 15.3 ±
11.5 days. 44 (71%) patients had squamous cell
carcinoma, while 18 (29%) patients had adenocarcinoma.
According to the histopathological stage of disease, 1
patient had T1 disease, 21 (33.9%) patients had T2 disease,
37 (59.7%) patients had T3 disease and 3 (4.8%) patients
had T4 disease. While 42 (67.7%) patients had nodal
involvement.
Accuracy, Sensitivity and Specificity of CT for correctly
diagnosing T2 tumours were 66% (13+28/62), 61%
(13/13+8) and 68% (28/28+13) as shown in Table-1.
Accuracy, Sensitivity and Specificity of CT for correctly
diagnosing T3 tumours were 63% (25+14/62), 67%
(25/25+12) and 56% (14/14+11) as shown in Table-2.
Accuracy, Sensitivity and Specificity of CT for correctly
detecting nodal disease were 65% (25+15/62), 59%
(25/25+17) and 75% (15/15+5) as shown in Table-3.
Discussion
According to our data Accuracy, sensitivity and specificity
of CT for T2 are 66%, 61% and 68%. Accuracy, sensitivity
and specificity of CT for T3 are 63%, 67% and 56%.
Accuracy, sensitivity and specificity of CT for nodal disease
are 65%, 59% and 75%.
Similar studies were done recently by Jeongmin et al.4
with sample size of 109 and he calculated Accuracy,
sensitivity and specificity of CT scan for Nodal status of
disease which was found to be 63%, 35%, and 93%.
Moschetta et al.5 calculated Accuracy, sensitivity and
specificity of CT scan for tumour status of disease which
was reported to be 79%, 67% and 64% in a sample of 31
patients. Chengg et al.6 reported sensitivity of CT scan to
be 100% for tumour size and 80% for nodal status of
disease in 50 patients. EPM van vliet7 reviewed 943
patients to find 50% sensitivity and 83% specificity of CT
scan for nodal disease.
NCCN guidelines now recommend using adjunct imaging
modalities along with CT scan to stage esophageal
cancers accurately. These modalities include Endoscopic
US and PET-CT. But the issue with these modalities is cost
and availability. EUS costs about £1800 and PET-CT costs
about £1000 in the UK, and in countries where the patient
has to bear the cost of his/her treatment, finances are a
major concern. In order to solve the issue, there are some
other techniques to increase the sensitivity and specificity
of CT scan. One of these is a vessel probe CT scans in
which after giving a small amount of oral contrast,
effervescent granules are swallowed, which produce gas
in the esophagus, causing distension of strictured
esophagus resulting in an increase in sensitivity and
specificity of CT scan from 68% to 89% when compared
with final histology.8
To make the study more significant separate calculation of
sensitivity and specificity for different stages of tumour
was done and the CT staging was performed by a
consultant radiologist who was blinded for the
histopathological stage of the disease. Weakness
included small sample size.
Conclusion
From this data, we can conclude that routine CT scans
alone have a low diagnostic accuracy for staging of
esophageal cancer and we should include another
staging tool with CT scan to properly stage tumours and
direct further treatment towards the right direction.
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